CAR-T Therapy for Central Nervous System B-cell Acute Lymphocytic Leukemia
Clinical trial NCT03064269 · UNKNOWN
Trial details
- NCT number
- NCT03064269
- Sponsor
- Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2024-12-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.